Related references
Note: Only part of the references are listed.Species Cross-Reactivity of Antibodies Used to Treat Ophthalmic Conditions
Yazad Irani et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2016)
Current phase 1/2 research for neovascular age-related macular degeneration
Paula E. Pecen et al.
CURRENT OPINION IN OPHTHALMOLOGY (2015)
Synthesis and Biological Evaluation of Novel Homoisoflavonoids for Retinal Neovascularization
Halesha D. Basavarajappa et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
A Simple Optical Coherence Tomography Quantification Method for Choroidal Neovascularization
Rania S. Sulaiman et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2015)
Natural product inhibitors of ocular angiogenesis
Rania S. Sulaiman et al.
EXPERIMENTAL EYE RESEARCH (2014)
Beta-lapachone inhibits pathological retinal neovascularization in oxygen-induced retinopathy via regulation of HIF-1a
Sung Wook Park et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2014)
The first synthesis of the antiangiogenic homoisoflavanone, cremastranone
Bit Lee et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2014)
Chemical constituents and cytotoxic activity from the fruits of Koelreuteria henryi
CH Lin et al.
PLANTA MEDICA (2014)
Reliability of the Mouse Model of Choroidal Neovascularization Induced by Laser Photocoagulation
Stephen H. Poor et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2014)
Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature
K. Ghasemi Falavarjani et al.
EYE (2013)
Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice
Vincent Lambert et al.
NATURE PROTOCOLS (2013)
Angiogenesis and Its Therapeutic Opportunities
So Young Yoo et al.
MEDIATORS OF INFLAMMATION (2013)
Choroid Sprouting Assay: An Ex Vivo Model of Microvascular Angiogenesis
Zhuo Shao et al.
PLOS ONE (2013)
Aflibercept (VEGF Trap-eye): the newest anti-VEGF drug
Michael W. Stewart
BRITISH JOURNAL OF OPHTHALMOLOGY (2012)
Global Prevalence and Major Risk Factors of Diabetic Retinopathy
Joanne W. Y. Yau et al.
DIABETES CARE (2012)
ß-Secretase (BACE1) inhibition causes retinal pathology by vascular dysregulation and accumulation of age pigment
Jun Cai et al.
EMBO MOLECULAR MEDICINE (2012)
The Expanding Role of Vascular Endothelial Growth Factor Inhibitors in Ophthalmology
Michael W. Stewart
MAYO CLINIC PROCEEDINGS (2012)
Natural products: An evolving role in future drug discovery
Bhuwan B. Mishra et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Molecular mechanisms and clinical applications of angiogenesis
Peter Carmeliet et al.
NATURE (2011)
Bioinformatic identification and characterization of human endothelial cell-restricted genes
Manoj Bhasin et al.
BMC GENOMICS (2010)
Age-related macular degeneration: Current and novel therapies
Pradeep S. Prasad et al.
MATURITAS (2010)
Endophthalmitis After Anti-VEGF Injections
Kathryn S. Klein et al.
OPHTHALMOLOGY (2009)
Selective Inhibition of Retinal Angiogenesis by Targeting PI3 Kinase
Yolanda Alvarez et al.
PLOS ONE (2009)
Complications in patients after intravitreal injection of bevacizumab
Chiharu Shima et al.
ACTA OPHTHALMOLOGICA (2008)
Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy
R. Simo et al.
DIABETOLOGIA (2008)
Endogenous VEGF Is Required for Visual Function: Evidence for a Survival Role on Muller Cells and Photoreceptors
Magali Saint-Geniez et al.
PLOS ONE (2008)
Homoisoflavanone inhibits retinal neovascularization through cell cycle arrest with decrease of cdc2 expression
Jeong Hun Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Non-responders to bevacizumab (Avastin) therapy of choroidal neovascular lesions
Anja Lux et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2007)
Molecular understanding and modern application of traditional medicines: Triumphs and trials
Timothy W. Corson et al.
CELL (2007)
Ocular neovascularization: Basic mechanisms and therapeutic advances
Michael Dorrell et al.
SURVEY OF OPHTHALMOLOGY (2007)
Mechanisms of disease: Age-related macular degeneration
Paulus T. V. M. de Jong
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Age-related macular degeneration - emerging pathogenetic and therapeutic concepts
Karen M. Gehrs et al.
ANNALS OF MEDICINE (2006)
Pegaptanib for wet macular degeneration
FW Fraunfelder
DRUGS OF TODAY (2005)
Anti-angiogenic activity of a homoisoflavanone from Cremastra appendiculata
JS Shim et al.
PLANTA MEDICA (2004)
Squalamine lactate reduces choroidal neovascularization in a laser-injury model in the rat
TA Ciulla et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2003)
Systematic discovery of multicomponent therapeutics
AA Borisy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Long-term follow-up of unilateral pallidotomy in advanced Parkinson's disease
J Fine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
